{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:28:52Z","timestamp":1793298532572,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00415-019-09316-x","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T14:03:16Z","timestamp":1555682596000},"page":"1693-1697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["High-intensity training in patients with spinal and bulbar muscular atrophy"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-8421","authenticated-orcid":false,"given":"Karen","family":"Heje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grete","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"issue":"4","key":"9316_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1212\/01.wnl.0000341274.61236.02","volume":"72","author":"N Preisler","year":"2009","unstructured":"Preisler N, Andersen G, Thogersen F, Crone C, Jeppesen TD, Wibrand F et al (2009) Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease). Neurology 72(4):317\u2013323","journal-title":"Neurology"},{"issue":"7","key":"9316_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/acn3.208","volume":"2","author":"JA Shrader","year":"2015","unstructured":"Shrader JA, Kats I, Kokkinis A, Zampieri C, Levy E, Joe GO et al (2015) A randomized controlled trial of exercise in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol 2(7):739\u2013747","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"9316_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/mus.24527","volume":"52","author":"KL Madsen","year":"2015","unstructured":"Madsen KL, Hansen RS, Preisler N, Th\u00f8gersen F, Berthelsen MP, Vissing J (2015) Training improves oxidative capacity, but not function, in spinal muscular atrophy type III. Muscle Nerve 52(2):240\u2013244","journal-title":"Muscle Nerve"},{"key":"9316_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12031-015-0686-3","volume":"58","author":"JR Dahlqvist","year":"2015","unstructured":"Dahlqvist JR, Vissing J (2015) Exercise therapy in spinobulbar muscular atrophy and other neuromuscular disorders. J Mol Neurosci 58:388\u2013393","journal-title":"J Mol Neurosci"},{"issue":"4","key":"9316_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1249\/mss.0b013e3180304570","volume":"39","author":"J Helgerud","year":"2007","unstructured":"Helgerud J, H\u00f8Ydal K, Wang E, Karlsen T, Berg P, Bjerkaas M et al (2007) Aerobic high-intensity intervals improve VO2max more than moderate training. Med Sci Sports Exerc 39(4):665\u2013671","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"9316_CR6","doi-asserted-by":"publisher","first-page":"R966","DOI":"10.1152\/ajpregu.00666.2007","volume":"294","author":"FM Iaia","year":"2008","unstructured":"Iaia FM, Thomassen M, Kolding H, Gunnarsson T, Wendell J, Rostgaard T et al (2008) Reduced volume but increased training intensity elevates muscle Na\u2009+\u2009\u2013K\u2009+\u2009pump \u03b11-subunit and NHE1 expression as well as short-term work capacity in humans. Am J Physiol Regul Integr Comp Physiol 294(3):R966\u2013R974","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"10","key":"9316_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/00005768-199610000-00018","volume":"28","author":"I Tabata","year":"1996","unstructured":"Tabata I, Nishimura K, Kouzaki M, Hirai Y, Ogita F, Miyachi M et al (1996) Effects of moderate-intensity endurance and high-intensity intermittent training on anaerobic capacity and [spacing dot above]VO2max. [Miscellaneous Article]. Med Sci Sports Exerc 28(10):1327\u20131330","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"9316_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1152\/japplphysiol.00334.2012","volume":"113","author":"TP Gunnarsson","year":"2012","unstructured":"Gunnarsson TP, Bangsbo J (2012) The 10-20-30 training concept improves performance and health profile in moderately trained runners. J Appl Physiol 113(1):16\u201324","journal-title":"J Appl Physiol"},{"issue":"1","key":"9316_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Statement","year":"2002","unstructured":"Statement ATS (2002) Am J Respir Crit Care Med 166(1):111\u2013117","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"9316_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/JND-150101","volume":"2","author":"J Montes","year":"2015","unstructured":"Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S et al (2015) Single-blind, randomized, controlled clinical trial of exercise in ambulatory spinal muscular atrophy: why are the results negative? J Neuromuscular Dis 2(4):463\u2013470","journal-title":"J Neuromuscular Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09316-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09316-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09316-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:29:36Z","timestamp":1587166176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09316-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["9316"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09316-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"assertion":[{"value":"6 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Andersen, Dr. Heje, and Dr. Buch reports no disclosure. Dr. Vissing reports having received research and travel support, and\/or speaker honoraria from Sanofi\/Genzyme, Ultragenyx Pharmaceuticals, Santhera Pharmaceuticals and aTyr Pharma, and served as consultant on advisory boards for Sanofi\/Genzyme, aTyr pharma, Ultragenyx Pharmaceuticals, Santhera Pharmaceuticals, Sarepta Therapeutics, NOVO Nordisk, Alexion Pharmaceuticals and Stealth Biotherapeutics within the last 3\u00a0years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}